From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Amphinex is a photosensitising agent used in photodynamic therapy for treating superficial cancers.

It has had promising preliminary results in early trials on patients with advanced head and neck cancer[1] [2] [3]


  1. ^ "Archived copy". Archived from the original on 2011-07-24. Retrieved 2010-04-06. Successful completion of the third dose group in the Amphinex study. March 2010
  2. ^ PCI Biotech Reports Successful Completion Of Second Dose Group In Pivotal Amphinex(R) Trial. Jan 2010
  3. ^ "Inoperable cancers killed by new laser surgery" The Times. UK. 3-April-2010 p15